all report title image

CELL CULTURE MARKET ANALYSIS

Cell Culture Market, By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Tissue Culture & Engineering, Toxicity Testing, Drug Development, Cell & Gene Therapy, and Others), By End User (Biopharmaceutical Companies, Hospitals & Diagnostic Laboratories, CMO & CRO, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Mar 2024
  • Code : CMI116
  • Pages :160
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Regional Analysis

Cell Culture Market Regional Insights

To learn more about this report, request sample copy

North America has established itself as the leading region in the global cell culture market and is expected to hold 39.7% of the market share in 2024. The presence of top pharmaceutical and biotechnology companies in countries like the U.S. has provided a major boost. There is a strong focus on R&D activities related to cell-based research by both private players as well as government institutes. This has led to a massive demand for cell culture equipment, media, and reagents as all new drug development processes now involve extensive cell-based testing. The cell therapy industry is also witnessing rapid growth in the U.S. due to efforts by companies developing new treatment options for chronic diseases. Many global players have set up their cell therapy research centers in North America to gain from the business-friendly environment and access to the talent pool. As more therapies reach the market in the coming years, the North American cell culture market is expected to further strengthen its dominant position.

The Asia Pacific region has emerged as the fastest-growing market for cell culture over the last five years. China, in particular, has emerged as a global force in pharmaceuticals and biologics, with the government focusing on building a robust healthcare ecosystem. Aggressive investments are being made to ramp up domestic R&D and manufacturing capabilities. Countries such as China, India, South Korea, and Singapore are offering attractive incentives to global players to set up facilities. This has led to a surge in infrastructure development for cell-based research. Additionally, the lower costs have prompted many global corporations to outsource certain testing activities to the region. Many biotech startups are also mushrooming with access to risk capital. With its massive population and growing healthcare needs, Asia Pacific's cell culture market is all set to witness exponential growth going forward to meet both the domestic and global demand.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.